Surrogate measurements of an effect of CTL infusion remain a crucial component of these studies. Compelling results have been obtained regarding sustained T-cell persistence and traffi cking using "gene marking" in which adoptively transferred CTLs were serially detected by polymerase chain reaction (PCR) amplifi cation in the peripheral blood and tumor biopsies of treated patients. 3, 8, 9 In recent studies, PCR amplifi cation was also used to detect the persistence and localization of CAR-modifi ed T lymphocytes. 6, 10 In addition to describing the presence of T cells, the functional status of infused T cells has been demonstrated by interferon-γ ELISPOT assay and major histocompatibility complex multimers used to quantify the frequency of CTL precursors. [1] [2] [3] 11 A limitation of repetitive measurements of T-cell number and function based on longitudinal sampling of blood and tumor is that it does not allow assessment of the dynamic and spatial-temporal distribution of adoptively transferred CTLs. This limitation can be overcome by the application of noninvasive, accurate, and sensitive whole-body imaging technologies allowing repetitive measurement in vivo of these cells. This could be achieved by repetitive positron Carlsbad, CA] 45%, Click's medium [Irvine Scientifi c, Santa Ana, CA] 45%, supplemented with 10% fetal bovine serum [FBS] and 2 mmol/L l -glutamine [GIBCO-BRL]). By day 20 of culture, more than 1 × 10 9 cells LNGFR + cells were obtained. Transduction effi ciency of the T cells was evaluated by immunophenotyping for LNGFR expression. Cells were stained with PE-conjugated anti-LNGFR and CD3allophycocyanin (APC) or CD4-and CD8-APC monoclonal antibodies (all from Becton-Dickinson, Mountain View, CA). Cells were analyzed by a FACScan (Becton Dickinson) equipped with the set of fi lters for triple-label fl uorescence quantifi cation and sorting.
In Vitro Radiotracer Uptake Study
An aliquot of sr39HSV1-tk + T cells was used to measure the uptake of the radiotracer in vitro as previously described. 12 Briefl y, untransduced (control) and sr39HSV1-tk genetransduced T cells (3 × 10 6 ) were centrifuged at 500 rpm for 2 minutes, resuspended in 1.5 mL of RPMI medium containing 10% FBS plus 3 H-FEAU (0.1 μCi/mL) (Moravek, Brea, CA), and incubated for 120 minutes at 37°C in 10 cm 2 dishes. The cells were then transferred to 1.5 mL tubes and centrifuged at 500 rpm for 2 minutes. Supernatant aliquots (100 μL) were transferred to preweighed scintillation vials, the rest of the supernatant was removed by aspiration, and the cell pellet was snap-frozen on dry ice. The frozen pellets were transferred into the preweighed scintillation vials, weighed, and thoroughly disaggregated by vortexing in 0.5 mL of Soluene-350 (Perkin-Elmer, Boston, MA) until fully dissolved and clear. Thereafter, 4 mL of Insta-Fluor Plus scintillation reagent (Perkin-Elmer, Shelton, CT) was added to each vial, and radioactivity concentrations in samples were measured using a Packard Tri-Carb 3100TR scintillation counter (Perkin-Elmer, Shelton, CT). Radioactivity concentration ratios in cell pellet versus medium (dpm/g cells)/ (dpm/g medium) were determined (C/M ratio). Each assay was performed in triplicate. The C/M ratio values were plotted versus time of radiotracer accumulation, and a linear regression fi t was performed to calculate the rate of the radiotracer accumulation in cells over time ( Ki , mL/g/min, or min -1 ). The rate of the radiotracer accumulation in cells refl ects the level of sr39HSV1-tk gene expression.
Animal Anesthesia and sr39HSV1-tk + T-Cell Administration
Two healthy adult rhesus macaques (one male and one female with body weights of 13 kg and 8.2 kg, respectively) were used in this study. The macaques were housed separately in an emission tomography and computed tomography (PET-CT) imaging with 2Ј-fl uoro-2Ј-deoxy-1-β-D-arabinofuranosyl-5-iodouracil (FIAU), 9-(4-[ 18 F]fl uoro-3-(hydroxymethyl) butyl)guanine ( 18 F-FHBG), or 2Ј-[ 18 F]fl uoro-5-ethyl-1-beta-D-arabinofuranosyluracil ( 18 F-FEAU) of T cells genetically labeled to express the herpes simplex virus 1 thymidine kinase ( HSV1-tk ) reporter gene. Using this approach, HSV1-tk + CTLs have been effi ciently detected in small animals after the infusion of [ 131 I]FIAU or [ 124 I]FIAU by serial images obtained by scintigraphy or PET, respectively. 12, 13 Recently, Yaghoubi and colleagues reported the results of studies involving only a single patient with grade IV glioblastoma multiforme (a case report) and demonstrated that 18 F-FHBG PET can detect HSV1-tk + T lymphocytes infused intracranially into the site of tumor resection. 14 In this article, we report the results of repetitive 18 F-FEAU PET-CT imaging in two nonhuman primates, which demonstrated that activated autologous T lymphocytes transduced with a retroviral vector encoding for sr39HSV1-tk can be detected after intravenous infusion in discrete lymphoid organs and in the sites of infl ammation. The results of this preclinical study in nonhuman primates support the application of this technology to noninvasive repetitive imaging of spatial-temporal dynamics of biodistribution of intravenously administered adoptively transferred CTLs in human patients.
Materials and Methods

Retroviral Construct
A retroviral construct was generated encoding for mutant sr39HSV1-tk and a truncated form of low-affi nity nerve growth factor receptor (LNGFR). Retroviral supernatant was obtained from a stable PG13 retroviral packaging cell line. 15 
Activation, Transduction, and Expansion of Macaque T Lymphocytes
Peripheral blood was obtained from each of the two rhesus macaques (30 mL per animal, obtained in two blood draws) according to Institutional Animal Care and Use Committee (IACUC)-approved procedures. The peripheral blood mononuclear cells (PBMCs) were isolated and cryopreserved. The cells were then thawed, activated, and transduced as previously described. 6, 16, 17 Seven days after transduction, the NGFR + cells were selected using anti-LNGFR antibody-coated paramagnetic microbeads (Miltenyi, Auburn, CA) 18 and expanded over 20 days, using γ-irradiated human PBMCs, Epstein-Barr virus (EBV) immortalized lymphoblastoid cell lines, and interleukin-2 (100 U/mL) 16 (Proleukin, Chiron, Emeryville, CA) in complete medium (RPMI 1640 [GIBCO-BRL, were cross-normalized using Volume Display Program , Version 1.2 (Hermes Medical Solutions) to accurately compare images obtained on different days of this study. Circular regions of interest (ROI) were placed in the areas with the highest radioactivity as well as in the muscle tissue with a low level of activity. Maximal standardized uptake value (SUV) was calculated from each ROI using the formula SUV = measured activity concentration (Bq/g) × body weight (g)/injected activity (Bq), and the target-to-muscle SUV ratios (T/M ratios) were calculated. For the assessment of radioactivity accumulation in the lungs, the lung area in each transaxial plane on PET images was outlined manually based on corresponding CT images, and the mean SUVs for each slice and for the whole lungs were calculated (a total of 43 planes). Lung to muscle ratios were calculated as well.
PCR for sr39HSV1-tk Transgene Expression in Biopsy Samples
Peripheral blood samples were collected at different time points after T-cell infusion. Based on the PET-CT images, an ultrasound-guided core biopsy was obtained from the posterior neck region of the second animal, corresponding to the site of increased 18 F-FEAU accumulation at 7 days after T-cell infusion. DNA was extracted from PBMCs and from the needle biopsy using the Qiagen DNA extraction Kit (Qiagen, Valencia, CA). To detect the sr39HSV1-tk transgene, 200 ng of DNA was amplifi ed using PCR according to a standard procedure (35 cycles of amplifi cation were used). The sequences of primers used for PCR amplifi cation were HSV1-tk forward primer 5Ј-CCATAGCAACCGACGTACG-3Ј and HSV1-tk reverse primer 5Ј-GAATCGCGGCCAGCATA-3Ј. 20 To verify the identity of the sr39HSV-tk PCR fragment amplifi ed from the needle biopsy, the PCR product was subcloned into the Topo-TA vector (Invitrogen, Carlsbad, CA) and sequenced by DNA sequencing (CHRC Core Lab, Houston, TX).
Results and Discussion
Autologous sr39HSV1-tk + T lymphocytes were generated and infused into the rhesus macaques. Animal 1 (male) received 0.8 × 10 9 cells in 20 mL of saline solution, which were 90% viable and 81% LNGFR + . As shown in Figure 1 A and B , for macaque 1, these cells expressed high levels of LNGFR and showed a signifi cant in vitro uptake of the radiotracer 3 H-FEAU (40.6 ± 5.3) compared with control cells (1.7 ± 0.11). 18 F-FEAU PET images at baseline and 90 minutes and 7 days after sr39HSV1-tk + T-cell infusion are presented in Figure 1 , C to N . Prior to adoptive Association for Assessment and Accrediation of Laboratory Animal Care International (AAALAC)-accredited facility. The experiment was performed following M.D. Anderson Cancer Center guidelines for conducting nonhuman primate experiments and under an approved protocol (IACUC protocol #06-07-07281). Prior to the T-cell infusions and imaging, the macaques were premedicated with atropine sulfate and anesthetized with ketamine (10 mg/kg), both administered intramuscularly in the left psoas muscle region, and then intubated endotracheally. General inhalation anesthesia was maintained using 2% isofl urane in oxygen. Electrocardiography, pulse oxymetry, respiration rate, blood pressure, and body temperature were monitored throughout the duration of each imaging session.
Thirty minutes before administration, the sr39HSV1-tk + T cells were collected by centrifugation at 500 rpm, washed twice with phosphate-buffered solution, resuspended in a normal saline solution, and infused intravenously over 10 to 15 minutes via the left cubital vein. 18 
F-FEAU PET Imaging
The 18 F-FEAU was synthesized using methods described by us previously 13, 19 and administered intravenously at a dose of 10.9 MBq/kg (4 mCi/animal) via the right saphenous vein. PET or PET-CT scans were performed at 60 minutes after the tracer injection. For the fi rst macaque, the baseline PET imaging was performed 2 years prior to T-cell infusion on the ECAT Exact HR+ PET scanner (CTI/Siemens, Knoxville, TN). Repeat PET-CT imaging studies were performed at 90 minutes and 1 week after T-cell infusion on a GE Discovery ST-8 PET-CT scanner (General Electrical Medical System, Milwaukee, WI). For the second macaque, all of the PET-CT studies were performed on the GE Discovery ST-8 PET/ CT scanner at baseline (1 week before T-cell infusion) and 90 minutes, 1 day, and 7 days after the intravenous T-cell infusion. During each imaging session, a conventional, noncontracted CT scan was acquired from the head to the toe. Then the whole-body PET scan (from the head to midthighs) was started at 60 minutes after the 18 F-FEAU injection. PET images were acquired in two-dimensional mode for 3 minutes per bed position, with four bed positions in total. PET images were reconstructed using VUE Point reconstruction software (GE Healthcare), which uses ordered subset expectation maximization (OSEM) algorithm. Emission data were corrected for attenuation and scatter (using CT), random events, and dead-time losses using manufacturer's software.
The CT and PET data were transferred to a dedicated imaging analysis workstation (Hermes Browser, Version 3.0, Hermes Medical Solutions, Stockholm, Sweden). Images after sr39HSV1-tk + T-cell infusion, PET imaging demonstrated intensive accumulation of 18 F-FEAU-derived radioactivity in the areas of the left parotid gland and in the cervical lymph nodes (see Figure 1D ). PET images obtained 7 days after sr39HSV1-tk + T-cell infusion revealed higher levels of immunotherapy, the 18 F-FEAU-derived radioactivity on PET imaging was predominantly located in the liver, small intestine, kidneys, and urinary bladder, which is consistent with the normal routes of 18 F-FEAU excretion through the hepatobiliary and renal systems (see Figure 1C ). Ninety minutes Figure 1 . Repetitive PET-CT images of 18 F-FEAU distribution in the rhesus macaque 1 before and after injection of sr39HSV1-tk + autologous T lymphocytes. A illustrates the percentage of LNGFR + T lymphocytes, as assessed by FACS analysis using a monoclonal antibody detecting NGFR (Becton-Dickinson), 7 days after retroviral transduction and at the time of infusion after selection using LNGFR microbeads. B illustrates the uptake of [ 3 H]-FEAU by sr39HSV1-tk + T lymphocytes. Each assay was performed in triplicate. Sr39HSV1-tk + T cells exhibited a cell to medium uptake ratio of 40.6, 24.5× higher than the control. Columns represent means; bars indicate ± standard deviation. C to N illustrate the whole-body PET scan 60 minutes after the tracer injection. PET images were reconstructed, analyzed, and normalized as previously described. 12 90% viable, 81% LNGFR + ) with signifi cant in vitro uptake of the radiotracer ( Figure 2 A and B ) . At 90 minutes after sr39HSV1-tk + T-cell infusion, signifi cant accumulation of 18 F-FEAU was observed bilaterally, in the posterior cervical regions, which correspond with bilateral posterior cervical lymph nodes (SUV = 2.54 and 1.97 with T/M ratios of 4.21 and 3.25) (see Figure 2 D and H ). One day after sr39HSV1-tk + T-cell infusion, the level of 18 F-FEAU accumulation in these lymph nodes had signifi cantly decreased (SUV = 1.64 and 1.47 with T/M ratio = 2.33 and 1.77) ( Figure 2 E and I ). However, 1 week later, the level of 18 F-FEAU activity somewhat increased (SUV = 1.83 and 2.06 with T/M ratios of 2.26 and 2.56). In addition, a substantial level of 18 F-FEAU accumulation was also observed bilaterally in the areas of anterior cervical and axillary lymph nodes ( Table 2 and Figure 2 F and J ) . These results were similar to those observed in the fi rst animal (see Table 1 and Figure 1 ), suggesting that the accumulation of 18 F-FEAU radiotracer in the areas of cervical lymph nodes seems a reproducible pattern in these animals and could be due to a preferential localization of polyclonal sr39HSV1-tk + T cells in areas of chronic infl ammatory processes in the oronasopharyngeal region, which are common in these animals. Interestingly, the thymus also showed signifi cant 18 F-FEAU accumulation on days 1 and 7. In this second macaque, peripheral blood samples were obtained 4 and 7 days after sr39HSV1-tk + T-cell infusion. We found that circulating sr39HSV1-tk + T cells expressing LNGFR were detectable in blood by FACS analysis ( Figure 3A ) . Moreover, we also obtained a needle biopsy of a cervical lymph node in which a signifi cant uptake of the radiotracer was observed tracer accumulation in the areas of the right parotid gland and right supraclavicular lymph node (see Figure 1E and Table 1 ). This shift in radiotracer accumulation can be explained, at least in part, by the presence of a mild infl ammatory process in the oropharynx of this animal. At 90 minutes after sr39HSV1-tk + T-cell infusion, a significantly higher accumulation of 18 F-FEAU-derived radioactivity was observed in the left psoas muscle and left obturator externus muscle, particularly proximal to the femur, which disappeared from the images obtained 1 week later (see Figure 1M ). The location of increased accumulation of 18 F-FEAU in that area was at the site of the intramuscular anesthetic injections. It is conceivable that 3.5 hours later, the sr39HSV1-tk-expressing T cells injected into this animal accumulated in that site of infl ammation. This explanation seems plausible because 7 days later, no radioactivity was detectable in that area ( Figure 1N ) , whereas a higher accumulation of 18 F-FEAU-derived radioactivity was still present in the right posterior supraclavicular lymph node and right parotid gland ( Figure 1E ). Given that biopsy was not available for this animal, we can only speculate that the trauma-related infl ammation was responsible for this observation.
In animal (Figure 2 ) (female), the baseline 18 F-FEAU PET-CT images, obtained 1 week prior to sr39HSV1-tk + T-cell infusion, demonstrated similar biodistribution of the radiotracer as observed in animal 1 despite the images being obtained with a different scanner ( Figure 2 C and G ) . The sr39HSV1-tk + T-cell product infused in this second animal was similar to that infused in the fi rst animal (0.5 × 10 9 cells, quantitative analysis, we determined that the whole-lung radioactivity was 38.5% higher on the PET images obtained at 90 minutes following T-cell infusion compared with images obtained 1 week later, suggesting only a transient diffuse retention of T cells in lungs (see Table 1 ). The current study is substantially different from that of Yaghoubi and colleagues, for which a single imaging time point after direct injection of autologous human tk + T cells into the resected cranial tumor was reported. 14 Our study is the fi rst at 7 days after sr39HSV1-tk + T-cell infusion. In this sample, we confi rmed the presence of the sr39HSV1-tk transgene by deoxyribonucleic acid (DNA) PCR amplifi cation ( Figure 3B ) indicating that the specifi c accumulation of the radiotracer was due to the presence of sr39HSV1-tk + T cells. It is noteworthy that in the current study, we did not observe signifi cant accumulation of sr39HSV1-tk + T cells in the lung as frequently observed in imaging experiments conducted in small animals. 12 to demonstrate the feasibility of repetitive PET-CT imaging of spatial-temporal dynamics of distribution and traffi cking of sr39HSV1-tk reporter gene-expressing T cells in non human primates after intravenous administration.
We conclude that PET imaging with 18 F-FEAU may be used in future clinical trials to evaluate the biodistribution of adoptively transferred CTLs modifi ed to express the sr39HSV1-tk reporter gene or its variants. 21 This technology will ultimately allow for long-term monitoring of traffi cking patterns and persistence of the T cells in patients and facilitate critical improvements in T-cell therapy for cancer.
